National Cancer Institute - Executive Plaza North

The Epidemiology of Burkitt Lymphoma in East-African Children and Minors (EMBLEM) is a research initiative sponsored by the Intramural Research program of the National Cancer Institute, focused on investigating the infections, immunological, and genetic risk factors associated with Burkitt lymphoma in malaria-endemic regions of Uganda, Tanzania, and Kenya. Through comprehensive case control studies, EMBLEM aims to uncover the complexities of Burkitt lymphoma and identify potential therapeutic targets and biomarkers. EMBLEM employs a multidisciplinary approach, utilizing demographic data, questionnaire responses, serological tests, and genetic analysis to explore the risk factors for Burkitt lymphoma in children aged 0-15 years. Furthermore, the project encourages collaboration by sharing unique biological samples and field experience, thereby enhancing research opportunities in rural Africa. Generated from the website